{"transactions":[{"id":730250,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T10:13:31.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":13698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitutes an award of restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date."}],"balance_after":31031,"source":{"system":"sec-edgar","filing":"0001193125-26-276633","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000119312526276633/ownership.xml","form_type":"4"}},{"id":747850,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:14:05.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":10667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":34785,"source":{"system":"sec-edgar","filing":"0001484612-26-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461226000035/edgardoc.xml","form_type":"4"}},{"id":758582,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-29T20:02:55.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":1573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting."}],"balance_after":3608,"source":{"system":"sec-edgar","filing":"0001203567-26-000003","document":"wk-form4_1780084972.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120356726000003/wk-form4_1780084972.xml","form_type":"4"}},{"id":1082000,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:29:54.000Z","date":"2025-07-22","kind":"grant","planned":false,"acquired":true,"shares":17333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute an award of restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock."}],"balance_after":17333,"source":{"system":"sec-edgar","filing":"0000950170-25-098533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000095017025098533/ownership.xml","form_type":"4"}},{"id":1090525,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-08T20:22:49.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":2035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on July 7, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":2035,"source":{"system":"sec-edgar","filing":"0001388658-25-000184","document":"wk-form4_1752006159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000138865825000184/wk-form4_1752006159.xml","form_type":"4"}},{"id":1122824,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T20:29:29.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":8983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders"}],"balance_after":24118,"source":{"system":"sec-edgar","filing":"0001484612-25-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000057/edgardoc.xml","form_type":"4"}},{"id":1149146,"issuer":{"id":7026,"kind":"organization","name":"Outset Medical, Inc.","symbol":"OM"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-14T21:06:40.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":15135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted to the reporting person on May 14, 2025.  Each RSU represents a contingent right to receive one share of common stock.  These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":15135,"source":{"system":"sec-edgar","filing":"0001484612-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1484612/000148461225000040/edgardoc.xml","form_type":"4"}},{"id":1179405,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T16:30:29.000Z","date":"2025-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus (\"Merger Sub\"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the \"Merger Consideration\"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-050464","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000095017025050464/ownership.xml","form_type":"4"}},{"id":1500295,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-28T18:55:47.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":19169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 23, 2024 or (ii) the next Annual Meeting following May 23, 2024, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,169 RSUs."}],"balance_after":43396,"source":{"system":"sec-edgar","filing":"0001610717-24-000264","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071724000264/form4.xml","form_type":"4"}},{"id":1874732,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-30T17:24:10.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":6754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,754 RSUs."}],"balance_after":24227,"source":{"system":"sec-edgar","filing":"0001610717-23-000078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000161071723000078/form4.xml","form_type":"4"}},{"id":2233872,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T00:05:24.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":103306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service."}],"balance_after":220978,"source":{"system":"sec-edgar","filing":"0001209191-22-036505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919122036505/doc4.xml","form_type":"4"}},{"id":2253288,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T21:00:03.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":4155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,155 restricted stock units."}],"balance_after":17473,"source":{"system":"sec-edgar","filing":"0001567619-22-011888","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761922011888/doc1.xml","form_type":"4"}},{"id":2469759,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T17:58:47.000Z","date":"2021-12-14","kind":"purchase","acquired":true,"shares":1400,"price":83.8,"value":117320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,183 restricted stock units."}],"balance_after":13318,"source":{"system":"sec-edgar","filing":"0001567619-21-022198","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761921022198/doc1.xml","form_type":"4"}},{"id":2469758,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T17:58:47.000Z","date":"2021-12-14","kind":"purchase","acquired":true,"shares":1000,"price":83.75,"value":83750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,183 restricted stock units."}],"balance_after":11918,"source":{"system":"sec-edgar","filing":"0001567619-21-022198","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761921022198/doc1.xml","form_type":"4"}},{"id":2667975,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T00:17:12.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2022 Annual Shareholders Meeting  or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Sientra, Inc. Class A Common Stock."}],"balance_after":117672,"source":{"system":"sec-edgar","filing":"0001209191-21-040774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919121040774/doc4.xml","form_type":"4"}},{"id":2695015,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T21:00:42.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2021 or (ii) the next Annual Meeting following May 25, 2021, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,183 RSUs."}],"balance_after":10918,"source":{"system":"sec-edgar","filing":"0001567619-21-011222","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761921011222/doc1.xml","form_type":"4"}},{"id":2741968,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T13:54:27.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":13426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Merger Agreement provides that each Option granted pursuant to a Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be accelerated and vest in full and (ii) to the extent not exercised prior to the Merger Effective Time, be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such canceled Option will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of (a) the number of Shares subject to such Option multiplied by (b) the excess, if any, of the Offer Price over the exercise price per Share under such Option; provided that, if the exercise price per Share of any such Option is equal to or greater than the Offer Price, then such Option will be canceled without any cash payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":4.38,"exercise_date":"2012-05-25","expiration_date":"2022-01-03","underlying":"Common Stock","underlying_shares":13426},"source":{"system":"sec-edgar","filing":"0001487371-21-000178","document":"wf-form4_161911404825662.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000178/wf-form4_161911404825662.xml","form_type":"4"}},{"id":2741967,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T13:54:27.000Z","date":"2021-04-22","kind":"other","acquired":false,"shares":131678,"price":24.05,"value":3166855.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated March 12, 2021, by and among Roche Holdings, Inc., a Delaware corporation (\"Parent\"), Geronimo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and GenMark Diagnostics, Inc., a Delaware corporation (the \"Company\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Parent caused Purchaser to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $24.05 per share (the \"Offer Price\"). On April 22, 2021 (the \"Merger Effective Time\"), the Company irrevocably accepted for payment all shares that were validly tendered and not withdrawn."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 28,128 RSUs. The Merger Agreement provides that each RSU awarded pursuant to any Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be fully accelerated and vest in full and the restrictions thereon shall lapse and (ii) be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such RSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001487371-21-000178","document":"wf-form4_161911404825662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000178/wf-form4_161911404825662.xml","form_type":"4"}},{"id":2846135,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T18:09:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan, which vest in full on June 1, 2022."}],"balance_after":131678,"source":{"system":"sec-edgar","filing":"0001487371-21-000050","document":"wf-form4_161377615935557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000050/wf-form4_161377615935557.xml","form_type":"4"}},{"id":2981164,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":7800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":25.2,"expiration_date":"2021-05-12","underlying":"Ordinary Shares","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981163,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":6448,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":18.04,"expiration_date":"2022-08-10","underlying":"Ordinary Shares","underlying_shares":6448},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981162,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":7538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":19.45,"expiration_date":"2023-08-09","underlying":"Ordinary Shares","underlying_shares":7538},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981161,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":6034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":21.66,"expiration_date":"2024-08-12","underlying":"Ordinary Shares","underlying_shares":6034},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981160,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":11018,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":11018},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981159,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":11765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":21.24,"expiration_date":"2026-07-19","underlying":"Ordinary Shares","underlying_shares":11765},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981158,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":10275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":10275},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981157,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":9907,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":9907},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981156,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":11691,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":11691},"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":2981155,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T15:51:15.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":16306,"price":30.75,"value":501409.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2019, Wright Medical Group N.V. (the \"Issuer\") entered into a purchase agreement (the \"Purchase Agreement\") with Stryker Corporation and its subsidiary, Stryker B.V. (the \"Purchaser\").  Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (\"Shares\"), of the Issuer (the \"Offer\"), and, on November 11, 2020 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 26,063 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001790300-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000179030020000004/primary_doc.xml","form_type":"4"}},{"id":3116014,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (RSUs)","published_at":"2020-06-09T22:25:24.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":27717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer."}],"balance_after":100802,"source":{"system":"sec-edgar","filing":"0001209191-20-035378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919120035378/doc4.xml","form_type":"4"}},{"id":3126972,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-02T17:58:46.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":17998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":121548,"source":{"system":"sec-edgar","filing":"0001487371-20-000199","document":"wf-form4_159113510817637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000199/wf-form4_159113510817637.xml","form_type":"4"}},{"id":3135035,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T14:32:31.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 21, 2020 or (ii) the next Annual Meeting following May 21, 2020, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,408 restricted stock units."}],"balance_after":9751,"source":{"system":"sec-edgar","filing":"0001567619-20-011148","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761920011148/doc1.xml","form_type":"4"}},{"id":3220394,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-09T11:22:22.000Z","date":"2020-03-06","kind":"purchase","acquired":true,"shares":10800,"price":4.53,"value":48924.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is the weighted average price per share.  Shares were purchased in multiple transactions at prices ranging from $4.52 to $4.54 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price."}],"balance_after":103550,"source":{"system":"sec-edgar","filing":"0001487371-20-000096","document":"wf-form4_158376732566820.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000096/wf-form4_158376732566820.xml","form_type":"4"}},{"id":3243857,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T20:52:39.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":3973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan in connection with his appointment as Chair of the Board of Directors, which vest in full on May 31, 2020."}],"balance_after":92750,"source":{"system":"sec-edgar","filing":"0001487371-20-000060","document":"wf-form4_158285474210927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000060/wf-form4_158285474210927.xml","form_type":"4"}},{"id":3434496,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":18050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Reporting Person was issued 1,180 shares of the Company's common stock pursuant to the net exercise of designated stock options. As a result, the Company withheld 16,870 shares of common stock underlying the exercised stock option for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2020-05-28","underlying":"Common Stock","underlying_shares":18050},"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434495,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was issued 1,635 shares of the Company's common stock pursuant to the net exercise of the designated stock options. As a result, the Company withheld 23,365 shares of common stock underlying the exercised stock options for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2020-05-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434494,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"tax_withholding","acquired":false,"shares":16870,"price":6.42,"value":108305.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person was issued 1,180 shares of the Company's common stock pursuant to the net exercise of designated stock options. As a result, the Company withheld 16,870 shares of common stock underlying the exercised stock option for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan."}],"balance_after":88777,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434493,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"tax_withholding","acquired":false,"shares":23365,"price":6.42,"value":150003.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The Reporting Person was issued 1,635 shares of the Company's common stock pursuant to the net exercise of the designated stock options. As a result, the Company withheld 23,365 shares of common stock underlying the exercised stock options for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan."}],"balance_after":105647,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434492,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":18050,"price":6,"value":108300.0,"ownership":{"direct":true},"balance_after":129012,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434491,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":25000,"price":6,"value":150000.0,"ownership":{"direct":true},"balance_after":110962,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434490,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":16150,"price":6.51,"value":105136.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person in June 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.54. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":85962,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3434489,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-19T17:15:22.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":2200,"price":6.51,"value":14322.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person in June 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.53. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":102112,"source":{"system":"sec-edgar","filing":"0001487371-19-000188","document":"wf-form4_156624930628938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000188/wf-form4_156624930628938.xml","form_type":"4"}},{"id":3453189,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T16:55:29.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":11691,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11691,"derivative":{"exercise_price":27.84,"exercise_date":"2020-07-26","expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":11691},"source":{"system":"sec-edgar","filing":"0001235802-19-000083","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000083/primary_doc.xml","form_type":"4"}},{"id":3453188,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-07-30T16:55:29.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":3916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,916 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":16306,"source":{"system":"sec-edgar","filing":"0001235802-19-000083","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000083/primary_doc.xml","form_type":"4"}},{"id":3485897,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (RSUs)","published_at":"2019-06-18T23:40:17.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":19320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer."}],"balance_after":73085,"source":{"system":"sec-edgar","filing":"0001209191-19-037837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919119037837/doc4.xml","form_type":"4"}},{"id":3493873,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-11T20:50:15.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":8696,"price":5.75,"value":50002.0,"ownership":{"direct":true},"balance_after":53765,"source":{"system":"sec-edgar","filing":"0001209191-19-036111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919119036111/doc4.xml","form_type":"4"}},{"id":3497088,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T16:30:43.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":1675,"price":60,"value":100500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,049 restricted stock units."}],"balance_after":8375,"source":{"system":"sec-edgar","filing":"0001567619-19-013060","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919013060/doc1.xml","form_type":"4"}},{"id":3502303,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-04T16:21:53.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":19851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":104312,"source":{"system":"sec-edgar","filing":"0001487371-19-000163","document":"wf-form4_155967969865439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000163/wf-form4_155967969865439.xml","form_type":"4"}},{"id":3515153,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T18:00:28.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":6049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. RSUs shall vest in three (3) equal annual installments on each anniversary of March 19, 2019, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,049 RSUs."}],"balance_after":6700,"source":{"system":"sec-edgar","filing":"0001567619-19-011870","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919011870/doc1.xml","form_type":"4"}},{"id":3582912,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-21T20:36:23.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the next Annual Meeting of the Stockholders following March 19, 2019, subject to the Reporting Person's continued service to the issuer."}],"balance_after":651,"source":{"system":"sec-edgar","filing":"0001567619-19-007426","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444380/000156761919007426/doc1.xml","form_type":"4"}},{"id":3612453,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-03-05T16:34:16.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":6417,"price":32,"value":205344.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":12390,"source":{"system":"sec-edgar","filing":"0001235802-19-000021","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000021/primary_doc.xml","form_type":"4"}},{"id":3645912,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-02-20T16:17:21.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":3583,"price":32.0066,"value":114679.6478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.03, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":18807,"source":{"system":"sec-edgar","filing":"0001235802-19-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000014/primary_doc.xml","form_type":"4"}},{"id":3679648,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-31","kind":"exercise","acquired":false,"shares":30816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":22.5,"expiration_date":"2020-06-03","underlying":"Ordinary Shares","underlying_shares":30816},"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3679647,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-30","kind":"exercise","acquired":false,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":30816,"derivative":{"exercise_price":22.5,"expiration_date":"2020-06-03","underlying":"Ordinary Shares","underlying_shares":1907},"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3679646,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-31","kind":"sale","acquired":false,"shares":30816,"price":30.0677,"value":926566.2432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.19, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":22390,"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3679645,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-31","kind":"exercise","acquired":true,"shares":30816,"price":22.5,"value":693360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":53206,"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3679644,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-30","kind":"sale","acquired":false,"shares":1907,"price":30,"value":57210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":22390,"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3679643,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-02-01T16:19:49.000Z","date":"2019-01-30","kind":"exercise","acquired":true,"shares":1907,"price":22.5,"value":42907.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":24297,"source":{"system":"sec-edgar","filing":"0001235802-19-000010","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000010/primary_doc.xml","form_type":"4"}},{"id":3764596,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-13","kind":"exercise","acquired":false,"shares":4537,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option has fully vested."}],"balance_after":32723,"derivative":{"exercise_price":22.5,"expiration_date":"2020-06-03","underlying":"Ordinary Shares","underlying_shares":4537},"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3764595,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-12","kind":"exercise","acquired":false,"shares":12740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option has fully vested."}],"balance_after":37260,"derivative":{"exercise_price":22.5,"expiration_date":"2020-06-03","underlying":"Ordinary Shares","underlying_shares":12740},"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3764594,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-13","kind":"sale","acquired":false,"shares":4537,"price":30.0213,"value":136206.6381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":22390,"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3764593,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-13","kind":"exercise","acquired":true,"shares":4537,"price":22.5,"value":102082.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":26927,"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3764592,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":12740,"price":30.1437,"value":384030.738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.35, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":22390,"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3764591,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-11-14T16:09:07.000Z","date":"2018-11-12","kind":"exercise","acquired":true,"shares":12740,"price":22.5,"value":286650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018."}],"balance_after":35130,"source":{"system":"sec-edgar","filing":"0001235802-18-000163","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000163/primary_doc.xml","form_type":"4"}},{"id":3860859,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T20:43:26.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":9907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in two annual installments, on the one-year and two-year anniversaries of July 24, 2018."}],"balance_after":9907,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":9907},"source":{"system":"sec-edgar","filing":"0001235802-18-000113","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000113/primary_doc.xml","form_type":"4"}},{"id":3860858,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T20:43:26.000Z","date":"2018-07-25","kind":"tax_withholding","acquired":false,"shares":626,"price":24.83,"value":15543.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":22389,"source":{"system":"sec-edgar","filing":"0001235802-18-000113","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000113/primary_doc.xml","form_type":"4"}},{"id":3860857,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T20:43:26.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":3804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,390 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":23015,"source":{"system":"sec-edgar","filing":"0001235802-18-000113","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000113/primary_doc.xml","form_type":"4"}},{"id":3901373,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (RSUs)","published_at":"2018-06-08T00:25:19.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":6116,"price":20.44,"value":125011.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock underlying this grant of restricted stock will vest on the earlier to occur of: (i) the day prior to the annual meeting of stockholders for the year following the date of grant or (ii) the one (1) year anniversary of the annual meeting of stockholders of the year of grant, subject to continued service as a director of the Issuer."}],"balance_after":45069,"source":{"system":"sec-edgar","filing":"0001209191-18-036532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919118036532/doc4.xml","form_type":"4"}},{"id":3915433,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T19:02:21.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":18866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":84461,"source":{"system":"sec-edgar","filing":"0001487371-18-000128","document":"wf-form4_152763492790366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000128/wf-form4_152763492790366.xml","form_type":"4"}},{"id":3940729,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-09T21:05:17.000Z","date":"2018-05-07","kind":"purchase","acquired":true,"shares":7407,"price":13.5,"value":99994.5,"ownership":{"direct":true},"balance_after":38953,"source":{"system":"sec-edgar","filing":"0001209191-18-028904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000120919118028904/doc4.xml","form_type":"4"}},{"id":4251010,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T17:06:52.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":10275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in two annual installments, on the one-year and two-year anniversaries of July 25, 2017."}],"balance_after":10275,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":10275},"source":{"system":"sec-edgar","filing":"0001235802-17-000121","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000121/primary_doc.xml","form_type":"4"}},{"id":4251009,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-07-26T17:06:52.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":3586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,586 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":19211,"source":{"system":"sec-edgar","filing":"0001235802-17-000121","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000121/primary_doc.xml","form_type":"4"}},{"id":4253270,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-07-21T16:19:26.000Z","date":"2017-07-19","kind":"tax_withholding","acquired":false,"shares":1428,"price":27.58,"value":39384.24,"ownership":{"direct":true},"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001235802-17-000109","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000109/primary_doc.xml","form_type":"4"}},{"id":4272462,"issuer":{"id":108294,"kind":"organization","name":"Sientra, Inc.","symbol":"SIEN"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-26T23:36:46.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":12861,"price":9.72,"value":125008.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock underlying this grant of restricted stock will vest on the earlier to occur of: (i) day prior to the annual meeting of stockholders for the year following the date of grant, or (ii) the one-year anniversary of the annual meeting of stockholders of the year of grant, subject to continued service as a director."}],"balance_after":31546,"source":{"system":"sec-edgar","filing":"0000899243-17-017261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203567/000089924317017261/doc4.xml","form_type":"4"}},{"id":4301261,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T18:42:08.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":7832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the reporting person pursuant to the Issuer's 2010 Equity Incentive Plan, which vest in full on the first anniversary of the grant date."}],"balance_after":65595,"source":{"system":"sec-edgar","filing":"0001487371-17-000126","document":"wf-form4_149618411381160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000126/wf-form4_149618411381160.xml","form_type":"4"}},{"id":4342038,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-04-28T13:55:12.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":17.48,"expiration_date":"2024-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-028626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028626/doc4.xml","form_type":"4"}},{"id":4342037,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-04-28T13:55:12.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":10645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":6.34,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":10645},"source":{"system":"sec-edgar","filing":"0001209191-17-028626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028626/doc4.xml","form_type":"4"}},{"id":4342036,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-04-28T13:55:12.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":40871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":10.21,"expiration_date":"2021-07-28","underlying":"Common Stock","underlying_shares":40871},"source":{"system":"sec-edgar","filing":"0001209191-17-028626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028626/doc4.xml","form_type":"4"}},{"id":4342035,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2017-04-28T13:55:12.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":1391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This vested option was canceled and converted in the Merger into the right to receive cash equal to the number of shares subject to such option multiplied by the excess, if any, of the Merger Consideration over the exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":5.06,"expiration_date":"2022-06-14","underlying":"Common Stock","underlying_shares":1391},"source":{"system":"sec-edgar","filing":"0001209191-17-028626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028626/doc4.xml","form_type":"4"}},{"id":4342034,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-28T13:55:12.000Z","date":"2017-04-28","kind":"other","acquired":false,"shares":11985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc (\"Allergan\"), Blizzard Merger Sub, Inc. (\"Merger Sub\"), and the Issuer (the \"Merger Agreement\"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Merger Agreement, out of the total of 11,985 shares held by the Reporting Person, (i) 10,952 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the \"Merger Consideration\"), and (ii) 1,033 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc (\"Allergan\"), Blizzard Merger Sub, Inc. (\"Merger Sub\"), and the Issuer (the \"Merger Agreement\"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, out of the total of 11,985 shares held by the Reporting Person, (i) 10,952 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes (the \"Merger Consideration\"), and (ii) 1,033 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-028626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919117028626/doc4.xml","form_type":"4"}},{"id":4579021,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2016-10-17T16:22:07.000Z","date":"2016-10-13","kind":"tax_withholding","acquired":false,"shares":1177,"price":23.71,"value":27906.67,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,094 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan."}],"balance_after":17053,"source":{"system":"sec-edgar","filing":"0001235802-16-000318","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580216000318/primary_doc.xml","form_type":"4"}},{"id":4599918,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2016-09-19T11:26:05.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":10645,"derivative":{"exercise_price":6.34,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-16-141910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919116141910/doc4.xml","form_type":"4"}},{"id":4599917,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T11:26:05.000Z","date":"2016-09-15","kind":"sale","acquired":false,"shares":7500,"price":40.0816,"value":300612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.245, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":11985,"source":{"system":"sec-edgar","filing":"0001209191-16-141910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919116141910/doc4.xml","form_type":"4"}},{"id":4599916,"issuer":{"id":176636,"kind":"organization","name":"Zeltiq Aesthetics Inc","symbol":"ZLTQ"},"owners":[{"id":36286,"kind":"person","name":"OBOYLE KEVIN C","position":1,"cik":"0001203567","reported_name":"OBOYLE KEVIN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-19T11:26:05.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":7500,"price":6.34,"value":47550.0,"ownership":{"direct":true},"balance_after":19485,"source":{"system":"sec-edgar","filing":"0001209191-16-141910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415336/000120919116141910/doc4.xml","form_type":"4"}}]}